Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1638 1651 1653 1796 1799
This examiner grants 67% of resolved cases
David W Berke-Schlessel is an examiner in Tech Center 1700 and Art Unit 1638, where he has overseen 751 resolved cases. His allowance rate of 66.7 percent indicates that a majority of applications reach a successful conclusion. The median days to allowance is 1047, placing the typical timeline for a grant at a duration that practitioners should account for in their filing strategies.
A notable feature of this examiner's profile is the interview lift of 31.8 percent. This high lift suggests that interviews are exceptionally effective at bridging the gap between the examiner's position and the applicant's goals. For practitioners, the data implies that an interview should be a standard part of the prosecution strategy to maximize the chances of allowance, especially given the volume of 751 cases supporting these figures. This approach can significantly improve the probability of a grant beyond the 66.7 percent baseline rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18437633 | NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | Non-Final OA | Allergan, Inc. |
| 18027816 | METHOD OF MANIPULATING ORGANISM AND DEVICE FOR MANIPULATING ORGANISM | Non-Final OA | NIKON CORPORATION |
| 18570470 | CHITINOLYTIC ENZYME-BASED PLANT PROTECTION AGENTS | Non-Final OA | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. |
| 17918933 | METHODS AND COMPOSITIONS FOR IMPROVING SC-BETA CELLS OR ENHANCING THEIR UTILITY | Final Rejection | WASHINGTON UNIVERSITY |
| 18609912 | METHOD AND SYSTEM FOR DETERMINING INTEGRATED METABOLIC BASELINE AND POTENTIAL OF LIVING CELLS | Final Rejection | Agilent Technologies, Inc. |
| 18837691 | METHODS AND COMPOSITIONS FOR TREATING DIABETES | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18277676 | GUEST-HOST SUPRAMOLECULAR ASSEMBLY OF INJECTABLE HYDROGEL NANOFIBERS FOR CELL ENCAPSULATION | Final Rejection | University of Virginia Patent Foundation |
| 18579230 | AGENT FOR IMPROVING INTESTINAL FLORA | Final Rejection | KEIO UNIVERSITY |
| 18286680 | METHOD FOR DETECTING EXOPOLYSACCHARIDE | Final Rejection | MEIJI CO., LTD. |
| 18706327 | REAGENT COMPOSITION AND KIT | Non-Final OA | DENKA COMPANY LIMITED |
| 18394679 | MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION | Non-Final OA | Native Microbials, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy